Monday, February 19, 2018
 
 
Company News: Page (1) of 1 - 09/08/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting
First Presentation of Detailed EVENITY ARCH Study Results and FRAME Extension Final Analysis10-Year Data From Long-Term Prolia FREEDOM Study
(September 08, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Manufacturing,Sales,Applications,Suppliers,Manufacturing/Production,Marketing,Insurance,Shipping & Receiving,Manufacturing,Sales & Marketing,Security,Business Issues,Administration,Legal,Management,Sales,Sales,Pro AV,Post/Production,Management,Presentors,Management,Business,Marketing,Business Issues,
Related Sites: Digital Producer ,   Digital Post Production ,   Presentation Master ,   DMN Newswire ,   itbusinessnet.com ,   IBN - Business ,   IBN - ProductivityApps ,   IBN - Security ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   KNews Newsletter ,   Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • BC Platforms to Provide Real World Evidence Solutions to Pfizer in Cardiovascular Diseases
  • Knee Bursitis Market 2018 | with ~7.1% of CAGR | A Definite Shift towards the Developing World | Forecasts till 2023
  • Worldwide Wound Closure Device Market is Expected to grow 21 billion by the end of the forecasted period, 2016-2022
  • Intralytix Receives FDA Clearance to Initiate Phase I / IIa Clinical Trials
  • Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration

    Cancer
  • Oasmia Pharmaceutical’s Docecal program achieves significant development milestone
  • PharmaMar Has Published the Results of Its Antibody Conjugate Active in Breast, Ovarian and Gastric Cancers that Express HER2
  • Digestive Center Launches ACTZYM, A Digestive Enzyme Designed to Optimize Overall Health and Wellness
  • Merrimack to Present at the 2018 RBC Capital Markets Global Healthcare Conference
  • MDxHealth Notice of Financial Year 2017 Results
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines